A New Chapter in Cancer Care: Pathfinder Lab Brings Genomic Hope to the Philippines

A transformative moment in Philippine healthcare is here. On May 8, 2025, L!NCS – the Linked Network for Cancer Services Inc. – officially launches Pathfinder Lab, a state-of-the-art genomic laboratory in the heart of Ortigas, Pasig City. The mission is simple yet powerful: to offer Filipino cancer patients a better, more precise way to fight the disease.

For many families, cancer feels like an overwhelming journey—one filled with difficult decisions, vague treatment paths, and side effects that can be just as hard as the illness itself. The uncertainty alone can weigh heavily on patients and their loved ones.

But now, there’s reason to hope. Pathfinder Lab introduces a cutting-edge approach known as genomic testing—an innovation that reshapes how cancer is diagnosed and treated. Rather than relying on broad, general methods, this testing focuses on what makes each patient’s cancer unique.

Genomic testing works by decoding the genetic makeup of a tumor through Next-Generation Sequencing (NGS). Think of it like fingerprinting cancer—finding the exact mutations responsible and identifying which treatments will be most effective.

3a078505 8382 466e 843f 651346b93a13
From left to right: Hiteshi Goswani CEO, 4baseCare Catherine Teh, MD Chair of the Board, LINCS Jhade Lotus Peneyra, MD- Finance Director, LINCS Necy Juat, MD- Director for Operations, LINCS Christina Galvez, MD – HR Director, LINCS Praveen Jha- VP Global Business Devt, 4baseCar

This means that doctors can now choose medications that specifically target a patient’s cancer type, avoid treatments that won’t work, reduce unwanted side effects, and start treatment plans with greater confidence and speed.

For the first time, this breakthrough technology is available locally. In the past, getting genomic tests meant sending samples abroad, incurring high costs and long waits. With Pathfinder Lab’s partnership with global oncology leader 4baseCare, patients can now access world-class diagnostics without leaving the country.

It’s a game-changer not just for patients but for the healthcare system. Pathfinder Lab aligns with the vision of the National Integrated Cancer Control Act, which seeks to make advanced cancer care more accessible and affordable for Filipinos.

Who stands to benefit? The answer is broad. From patients with hard-to-treat or recurring cancers to newly diagnosed individuals hoping for a clearer treatment path, even families wanting to understand their genetic risk—genomic testing offers critical insight.

Pic1

Doctors, too, gain a powerful ally. When traditional treatments fall short, genomic data can unlock better options, guiding decisions with precision rather than guesswork.

Beyond the science lies something even more vital: empowerment. Cancer can take away control, but understanding one’s genetic profile gives it back. With the right information at the right time, patients gain not only better outcomes but renewed hope.

L!NCS’ Pathfinder Lab is more than a laboratory—it’s a beacon for Filipino families facing one of life’s toughest battles. It offers clarity in chaos and personalized care in a system often dominated by one-size-fits-all solutions.

To learn more about how genomic testing is changing lives and redefining cancer care, visit www.lincsconsulting.com. Hope, it turns out, may already be in your DNA.

ABOUT THE AUTHOR

JUST IN

More Stories